Displaying items 81-100 of 49765 in total

How Standardized Ultrasound is Reshaping the Economics of GI Clinical Trials

Read full article
BriefGlance

Securing the Future of American Nuclear Fuel: The Laser Enrichment Bet

Read full article
Securing the Future of American Nuclear Fuel: The Laser Enrichment Bet

Strattec's Q1 FY2027 Earnings: A Litmus Test for Auto Sector Resilience

Read full article
Strattec's Q1 FY2027 Earnings: A Litmus Test for Auto Sector Resilience

The AI Productivity Paradox: Why Execution is Stalling Over Hidden Skill Gaps

Read full article
The AI Productivity Paradox: Why Execution is Stalling Over Hidden Skill Gaps

Streaming the Sweet Science: How TBL's Prime Video Deal Signals a New Era for Combat Sports

Read full article
Streaming the Sweet Science: How TBL's Prime Video Deal Signals a New Era for Combat Sports

OpenAI Enlists Innover to Push Agentic AI Beyond the Pilot Graveyard

Read full article
OpenAI Enlists Innover to Push Agentic AI Beyond the Pilot Graveyard

Wall Street Bets on the Nuclear Renaissance: Inside the SMRZ ETF

Read full article
Wall Street Bets on the Nuclear Renaissance: Inside the SMRZ ETF

AI Without the Overhaul: Alpha Modus Pilots Legacy Tech Integration in Grocery

Read full article
AI Without the Overhaul: Alpha Modus Pilots Legacy Tech Integration in Grocery

The $22 Trillion Crusade: Eventide's Trojan Horse for Faith-Based Advisors

Read full article
The $22 Trillion Crusade: Eventide's Trojan Horse for Faith-Based Advisors

Midea's European Pivot: How R290 and Indoor Heat Pumps Will Reshape HVAC

Read full article
Midea's European Pivot: How R290 and Indoor Heat Pumps Will Reshape HVAC

FedNow Hits the Bar: How Instant Payments Are Squeezing Card Fees

Read full article
FedNow Hits the Bar: How Instant Payments Are Squeezing Card Fees

The Bell Perspective: Uncorking Ardagh's $3 Billion Mega-Deal

Read full article
The Bell Perspective: Uncorking Ardagh's $3 Billion Mega-Deal

Redesigning Cell Therapy: How ET501 Targets High-Risk Neuroblastoma

Read full article
Redesigning Cell Therapy: How ET501 Targets High-Risk Neuroblastoma

The Dark Side of Medicare Open Enrollment: Deceptive Marketing Traps

Read full article
The Dark Side of Medicare Open Enrollment: Deceptive Marketing Traps

The Industry 4.0 Illusion: Why 94% of Manufacturers Cannot Connect Their Data

Read full article
The Industry 4.0 Illusion: Why 94% of Manufacturers Cannot Connect Their Data

The Supersized Studio: REFORMD's Mega-Capacity Bet on Luxury Fitness

Read full article
The Supersized Studio: REFORMD's Mega-Capacity Bet on Luxury Fitness

The AI Roll-Up: Why Sunbound Just Bought a Legacy Consulting Firm

Read full article
The AI Roll-Up: Why Sunbound Just Bought a Legacy Consulting Firm

Shift Browser Embeds Native Blocker as the Extension Era Wanes

Read full article
Shift Browser Embeds Native Blocker as the Extension Era Wanes

The End of the 'Dumb' Transaction: Why Event Intelligence is Banking's New Frontier

Read full article
The End of the 'Dumb' Transaction: Why Event Intelligence is Banking's New Frontier

GXO Powers Action’s Retail Boom With New 80,000-Sqm French Hub

Read full article
GXO Powers Action’s Retail Boom With New 80,000-Sqm French Hub